{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]P09874,1,P09874,156,0]["},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P09874","source":"P09874|Poly [ADP-ribose] polymerase 1","targets":["1UK0|Crystal structure of catalytic domain of human poly(ADP-ribose) polymerase with a novel inhibitor|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE","1UK1|Crystal structure of human poly(ADP-ribose) polymerase complexed with a potent inhibitor|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE","1WOK|Crystal structure of catalytic domain of human poly(ADP-ribose) polymerase complexed with a quinoxaline-type inhibitor|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE","2COK|Solution structure of BRCT domain of poly(ADP-ribose) polymerase-1|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2CR9|Solution structure of WGR domain of poly(ADP-ribose) polymerase-1|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2CS2|Solution structure of the second Zn-finger domain of poly(ADP-ribose) polymerase-1|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2DMJ|Solution structure of the first zf-PARP domain of human Poly(ADP-ribose)polymerase-1|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2JVN|Domain C of human PARP-1|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2L30|Human PARP-1 zinc finger 1|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2L31|Human PARP-1 zinc finger 2|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2N8A|1H, 13C and 15N chemical shift assignments and solution structure for PARP-1 F1F2 domains in complex with a DNA single-strand break|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","2RCW|PARP complexed with A620223|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE","2RD6|PARP complexed with A861695|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","2RIQ|Crystal Structure of the Third Zinc-binding domain of human PARP-1|X-RAY DIFFRACTION|1.7|Homo sapiens|0|TRANSFERASE","3GJW|PARP complexed with A968427|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","3GN7|PARP complexed with A861696|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE","3L3L|PARP complexed with A906894|X-RAY DIFFRACTION|2.5|Homo sapiens|0|Transferase/Transferase Inhibitor","3L3M|PARP complexed with A927929|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE","3OD8|Human PARP-1 zinc finger 1 (Zn1) bound to DNA|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","3ODA|Human PARP-1 zinc finger 1 (Zn1) bound to DNA|X-RAY DIFFRACTION|2.64|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","3ODC|Human PARP-1 zinc finger 2 (Zn2) bound to DNA|X-RAY DIFFRACTION|2.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","3ODE|Human PARP-1 zinc finger 2 (Zn2) bound to DNA|X-RAY DIFFRACTION|2.95|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","4AV1|Crystal structure of the human PARP-1 DNA binding domain in complex with DNA|X-RAY DIFFRACTION|3.1|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|TRANSFERASE","4DQY|Structure of Human PARP-1 bound to a DNA double strand break|X-RAY DIFFRACTION|3.25|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/DNA","4GV7|Human ARTD1 (PARP1) - Catalytic domain in complex with inhibitor ME0328|X-RAY DIFFRACTION|2.89|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4HHY|Crystal structure of PARP catalytic domain in complex with novel inhibitors|X-RAY DIFFRACTION|2.3637|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4HHZ|Crystal structure of PARP catalytic domain in complex with novel inhibitors|X-RAY DIFFRACTION|2.7199|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4L6S|PARP complexed with benzo[1,4]oxazin-3-one inhibitor|X-RAY DIFFRACTION|2.2|Homo sapiens|0|transferase/transferase inhibitor","4OPX|Structure of Human PARP-1 bound to a DNA double strand break in complex with (2R)-5-fluoro-2-methyl-2,3-dihydro-1-benzofuran-7-carboxamide|X-RAY DIFFRACTION|3.314|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/DNA/TRANSFERASE INHIBITOR","4OQA|Structure of Human PARP-1 bound to a DNA double strand break in complex with (2Z)-2-(2,4-dihydroxybenzylidene)-3-oxo-2,3-dihydro-1-benzofuran-7-carboxamide|X-RAY DIFFRACTION|3.65|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/DNA/TRANSFERASE INHIBITOR","4OQB|Structure of Human PARP-1 bound to a DNA double strand break in complex with (2Z)-2-{4-[2-(morpholin-4-yl)ethoxy]benzylidene}-3-oxo-2,3-dihydro-1-benzofuran-7-carboxamide|X-RAY DIFFRACTION|3.362|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE/DNA/TRANSFERASE INHIBITOR","4PJT|Structure of PARP1 catalytic domain bound to inhibitor BMN 673|X-RAY DIFFRACTION|2.35|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4R5W|Human artd1 (parp1) - catalytic domain in complex with inhibitor xav939|X-RAY DIFFRACTION|2.84|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4R6E|Human artd1 (parp1) - catalytic domain in complex with inhibitor niraparib|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4RV6|Human ARTD1 (PARP1) catalytic domain in complex with inhibitor Rucaparib|X-RAY DIFFRACTION|3.19|Homo sapiens|0|Transferase/Transferase inhibitor","4UND|HUMAN ARTD1 (PARP1) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TALAZOPARIB|X-RAY DIFFRACTION|2.2|HOMO SAPIENS|0|TRANSFERASE","4UXB|Human ARTD1 (PARP1) - Catalytic domain in complex with inhibitor PJ34|X-RAY DIFFRACTION|3.22|HOMO SAPIENS|0|TRANSFERASE","4XHU|The complex structure of Timeless_PAB and PARP-1_catalytic domain|X-RAY DIFFRACTION|2.089|Homo sapiens|0|TRANSFERASE/REPLICATION","4ZZZ|Structure of human PARP1 catalytic domain bound to an isoindolinone inhibitor|X-RAY DIFFRACTION|1.9|HOMO SAPIENS|0|TRANSFERASE","5A00|Structure of human PARP1 catalytic domain bound to an isoindolinone inhibitor|X-RAY DIFFRACTION|2.75|HOMO SAPIENS|0|TRANSFERASE","5DS3|Crystal structure of constitutively active PARP-1|X-RAY DIFFRACTION|2.6|Homo sapiens|0|Transferase/Transferase Inhibitor","5HA9|Crystal structure-based design and disovery of a novel PARP1 antiagonist (BL-PA10) that induces apoptosis and inhibits metastasis in triple negative breast cancer|X-RAY DIFFRACTION|4.01|Homo sapiens|0|Transferase/Transferase inhibitor","5KPN|Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5KPO|Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.65|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5KPP|Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.33|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5KPQ|Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5WRQ|Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.65|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5WRY|Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5WRZ|Structure of human PARP1 catalytic domain bound to a phthalazinone inhibitor|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5WS0|Structure of human PARP1 catalytic domain bound to a benzoimidazole inhibitor|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5WS1|Structure of human PARP1 catalytic domain bound to a benzoimidazole inhibitor|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5WTC|Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5XSR|novel orally efficacious inhibitors complexed with PARP1|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5XST|novel orally efficacious inhibitors complexed with PARP1|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5XSU|novel orally efficacious inhibitors complexed with PARP1|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6BHV|Human PARP-1 bound to NAD+ analog benzamide adenine dinucleotide (BAD)|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","6GHK|Human PARP1 (ARTD1) - Catalytic domain in complex with inhibitor ME0527|X-RAY DIFFRACTION|2.28|Homo sapiens|0|TRANSFERASE","6M3I|Crystal structure of HPF1/PARP1 complex|X-RAY DIFFRACTION|1.98|Homo sapiens|0|NUCLEAR PROTEIN","6NRF|Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT103|X-RAY DIFFRACTION|2|Homo sapiens|0|transferase/transferase inhibitor","6NRG|Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT57|X-RAY DIFFRACTION|1.7|Homo sapiens|0|transferase/transferase inhibitor","6NRH|Crystal Structure of human PARP-1 ART domain bound inhibitor UTT63|X-RAY DIFFRACTION|1.5|Homo sapiens|0|transferase/transferase inhibitor","6NRI|Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT83|X-RAY DIFFRACTION|2.2|Homo sapiens|0|transferase/transferase inhibitor","6NRJ|Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT93|X-RAY DIFFRACTION|1.65|Homo sapiens|0|transferase/transferase inhibitor","6NTU|Crystal Structure of human PARP-1 ART domain bound to inhibitor UKTT-15|X-RAY DIFFRACTION|1.8|Homo sapiens|0|transferase/transferase inhibitor","6VKK|Crystal Structure of human PARP-1 CAT domain bound to inhibitor rucaparib|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE/INHIBITOR","6VKO|Crystal Structure of human PARP-1 CAT domain bound to inhibitor UKTT15|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE/INHIBITOR","6VKQ|Crystal Structure of human PARP-1 CAT domain bound to inhibitor EB-47|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE/INHIBITOR","6XVW|Catalytic domain of human PARP-1 in complex with the inhibitor MC2050|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE","7AAA|Crystal structure of the catalytic domain of human PARP1 (apo)|X-RAY DIFFRACTION|1.74|Homo sapiens|0|TRANSFERASE","7AAB|Crystal structure of the catalytic domain of human PARP1 in complex with inhibitor EB-47|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE","7AAC|Crystal structure of the catalytic domain of human PARP1 in complex with veliparib|X-RAY DIFFRACTION|1.593|Homo sapiens|0|TRANSFERASE","7AAD|Crystal structure of the catalytic domain of human PARP1 in complex with olaparib|X-RAY DIFFRACTION|2.21|Homo sapiens|0|TRANSFERASE","7CMW|Complex structure of PARP1 catalytic domain with pamiparib|X-RAY DIFFRACTION|2.7|Homo sapiens|0|ANTITUMOR PROTEIN","7KK2|Structure of the catalytic domain of PARP1|X-RAY DIFFRACTION|1.695|Homo sapiens|0|TRANSFERASE","7KK3|Structure of the catalytic domain of PARP1 in complex with talazoparib|X-RAY DIFFRACTION|2.06|Homo sapiens|0|TRANSFERASE","7KK4|Structure of the catalytic domain of PARP1 in complex with olaparib|X-RAY DIFFRACTION|1.96|Homo sapiens|0|TRANSFERASE","7KK5|Structure of the catalytic domain of PARP1 in complex with niraparib|X-RAY DIFFRACTION|1.7|Homo sapiens|0|TRANSFERASE","7KK6|Structure of the catalytic domain of PARP1 in complex with veliparib|X-RAY DIFFRACTION|2.06|Homo sapiens|0|TRANSFERASE","7ONR|PARP1 catalytic domain in complex with 8-chloroquinazolinone-based inhibitor (compound 9)|X-RAY DIFFRACTION|2.05|Homo sapiens|0|TRANSFERASE","7ONS|PARP1 catalytic domain in complex with isoquinolone-based inhibitor (compound 16)|X-RAY DIFFRACTION|1.97|Homo sapiens|0|TRANSFERASE","7ONT|PARP1 catalytic domain in complex with a selective pyridine carboxamide-based inhibitor (compound 22)|X-RAY DIFFRACTION|1.853|Homo sapiens|0|TRANSFERASE","7S68|Structure of human PARP1 domains (Zn1, Zn3, WGR and HD) bound to a DNA double strand break.|X-RAY DIFFRACTION|3.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","7S6H|Human PARP1 deltaV687-E688 bound to NAD+ analog EB-47 and to a DNA double strand break.|X-RAY DIFFRACTION|3.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","7S6M|Human PARP1 deltaV687-E688 bound to a DNA double strand break.|X-RAY DIFFRACTION|3.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","7S81|Structure of human PARP1 domains (Zn1, Zn3, WGR, HD) bound to a DNA double strand break.|X-RAY DIFFRACTION|3.6|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN","7SCY|Nuc147 bound to single BRCT|ELECTRON MICROSCOPY|4.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","7SCZ|Nuc147 bound to multiple BRCTs|ELECTRON MICROSCOPY|3.5|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","8FYY|Crystal structure of human PARP1 ART domain bound to inhibitor UKTT5 (compound 10)|X-RAY DIFFRACTION|2.8|Homo sapiens|0|DNA BINDING PROTEIN/INHIBITOR","8FYZ|Crystal structure of human PARP1 ART domain bound to inhibitor UKTT10 (compound 13)|X-RAY DIFFRACTION|3.4|Homo sapiens|0|DNA BINDING PROTEIN/INHIBITOR","8FZ1|Crystal structure of human PARP1 ART domain bound to inhibitor UKTT22 (compound 14)|X-RAY DIFFRACTION|2.7|Homo sapiens|0|DNA BINDING PROTEIN/INHIBITOR","8G0H|Human PARP1 deltaV687-E688 bound to UKTT5 (compound 10) and to a DNA double strand break.|X-RAY DIFFRACTION|3.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA binding protein/DNA","8HE7|ADP-ribosyltransferase 1 (PARP1) catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE","8HLR|Human ADP-ribosyltransferase 1 (PARP1) catalytic domain bound to Fluzoparib (SHR3162)|X-RAY DIFFRACTION|2.85|Homo sapiens|0|TRANSFERASE","8JNZ|Human ADP-ribosyltransferase 1 (PARP1) catalytic domain bound to a pyrazolopyrimidine carboxamide inhibitor|X-RAY DIFFRACTION|2.84|Homo sapiens|0|TRANSFERASE","8U4W|The crystal structure of a helical domain deleted PARP1 in complex with isoindolinone based inhibitor.|X-RAY DIFFRACTION|3.02|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","8VYH|Crystal Structure Analysis of PARP1 in complex with a compound|X-RAY DIFFRACTION|2.05|Homo sapiens|0|TRANSFERASE/INHIBITOR","9BPY|Human PARP1 ART domain bound to NAD+ analogs benzamide adenine dinucleotide and carba-NAD+|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE","9CKC|Crystal structure of SMYD2 in complex with two PARP1 peptides|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","9DMC|Human PARP1 ART domain bound to NAD+ analog benzamide adenine dinucleotide and ADP-ribose|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE","9ETQ|Crystal structure of PARP1 catalytic domain bound to AZD5305 (SARUPARIB)|X-RAY DIFFRACTION|1.59|Homo sapiens|0|TRANSFERASE"]}]}